Difference between revisions of "Sources"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "http://www.thelancet.com" to "https://www.thelancet.com")
(7 intermediate revisions by 2 users not shown)
Line 1: Line 1:
Knowledge aggregation sites such as HemOnc.org could not exist without primary sources. We access primary sources through a variety of means, including subscription to eTOCs, conference proceedings, and customized e-mail alerts through [https://www.ncbi.nlm.nih.gov/pubmed/ PubMed] and other sources. This is a list of the sources that we use most frequently; decisions on whether to include treatment regimens are informed by our [[eligibility criteria]].
+
Knowledge aggregation sites such as HemOnc.org could not exist without primary sources. We access primary sources through a variety of means, including subscription to eTOCs, conference proceedings, and customized e-mail alerts through [https://pubmed.ncbi.nlm.nih.gov/ PubMed] and other sources. This is a list of the sources that we use most frequently; decisions on whether to include treatment regimens are informed by our [[eligibility criteria]].
  
 
="Top-tier" general medical journals=
 
="Top-tier" general medical journals=
 
*[https://jamanetwork.com/journals/jama/ JAMA]
 
*[https://jamanetwork.com/journals/jama/ JAMA]
 
*[https://www.thelancet.com/ The Lancet]
 
*[https://www.thelancet.com/ The Lancet]
*[http://www.nejm.org/ The New England Journal of Medicine]
+
*[https://www.nejm.org/ The New England Journal of Medicine]
  
 
="Top-tier" hematology/oncology journals=
 
="Top-tier" hematology/oncology journals=
 
*[http://annonc.oxfordjournals.org/ Annals of Oncology] Official journal of the European Society for Medical Oncology (ESMO)
 
*[http://annonc.oxfordjournals.org/ Annals of Oncology] Official journal of the European Society for Medical Oncology (ESMO)
*[http://bloodjournal.hematologylibrary.org/ Blood] Official journal of the American Society of Hematology (ASH)
+
*[http://www.bloodjournal.org/ Blood] Official journal of the American Society of Hematology (ASH)
 
*[https://jamanetwork.com/journals/jamaoncology JAMA Oncology]
 
*[https://jamanetwork.com/journals/jamaoncology JAMA Oncology]
 
*[http://jco.ascopubs.org/ Journal of Clinical Oncology] Official journal of the American Society of Clinical Oncology (ASCO)
 
*[http://jco.ascopubs.org/ Journal of Clinical Oncology] Official journal of the American Society of Clinical Oncology (ASCO)
 +
*[https://www.thelancet.com/journals/lanhae/issue/current The Lancet Haematology]
 
*[https://www.thelancet.com/journals/lanonc/issue/current The Lancet Oncology]
 
*[https://www.thelancet.com/journals/lanonc/issue/current The Lancet Oncology]
  
 
=Other hematology/oncology journals=
 
=Other hematology/oncology journals=
 
*[http://www.bloodadvances.org/ Blood Advances]
 
*[http://www.bloodadvances.org/ Blood Advances]
*[http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2141 British Journal of Haematology] Official journal of the British Society for Haematology
+
*[https://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2141 British Journal of Haematology] Official journal of the British Society for Haematology
*[http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0142 Cancer] Published on behalf of the American Cancer Society (ACS)
+
*[https://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0142 Cancer] Published on behalf of the American Cancer Society (ACS)
 
*[http://clincancerres.aacrjournals.org/ Clinical Cancer Research]
 
*[http://clincancerres.aacrjournals.org/ Clinical Cancer Research]
 
*[http://www.clinical-lymphoma-myeloma-leukemia.com/ Clinical Lymphoma, Myeloma & Leukemia]
 
*[http://www.clinical-lymphoma-myeloma-leukemia.com/ Clinical Lymphoma, Myeloma & Leukemia]
Line 22: Line 23:
 
*[http://www.jhoonline.org/ Journal of Hematology & Oncology] Official journal of the Chinese American Hematologist and Oncologist Network
 
*[http://www.jhoonline.org/ Journal of Hematology & Oncology] Official journal of the Chinese American Hematologist and Oncologist Network
 
*[https://academic.oup.com/jnci Journal of the National Cancer Institute]
 
*[https://academic.oup.com/jnci Journal of the National Cancer Institute]
*[https://www.thelancet.com/journals/lanhae/issue/current The Lancet Haematology]
+
*[https://www.thelancet.com/journals/langas/home Lancet Gastroenterology and Hepatology]
*[http://www.nature.com/leu/index.html Leukemia]
+
*[https://www.thelancet.com/journals/laneur/home Lancet Neurology]
 +
*[https://www.nature.com/leu/index.html Leukemia]
 
*[https://www.tandfonline.com/loi/lal Leukemia & Lymphoma]
 
*[https://www.tandfonline.com/loi/lal Leukemia & Lymphoma]
 
*[http://www.seminoncol.org/ Seminars in Oncology]
 
*[http://www.seminoncol.org/ Seminars in Oncology]
Line 29: Line 31:
 
=Conference proceedings=
 
=Conference proceedings=
 
*[http://jco.ascopubs.org/site/meetings ASCO Annual Meeting Proceedings]
 
*[http://jco.ascopubs.org/site/meetings ASCO Annual Meeting Proceedings]
*[http://bloodjournal.hematologylibrary.org/site/misc/ASH_Meeting_Abstracts_Info.xhtml ASH Annual Meeting Abstracts]
+
*[http://www.bloodjournal.org/site/misc/ASH_Meeting_Abstracts_Info.xhtml ASH Annual Meeting Abstracts]
 
*[http://www.ehaweb.org/congress-and-events/annual-congress/previous-congresses-2/abstract-book/ EHA Abstract Book]
 
*[http://www.ehaweb.org/congress-and-events/annual-congress/previous-congresses-2/abstract-book/ EHA Abstract Book]
 
*[http://oncologypro.esmo.org/Science-Education/Scientific-Meeting-Reports ESMO Scientific Meeting Reports]
 
*[http://oncologypro.esmo.org/Science-Education/Scientific-Meeting-Reports ESMO Scientific Meeting Reports]
Line 38: Line 40:
 
*[http://www.researchtopractice.com/ Research to Practice]
 
*[http://www.researchtopractice.com/ Research to Practice]
  
[[Category:General reference pages]]
+
[[Category:Evidence-based oncology]]

Revision as of 00:32, 29 August 2023

Knowledge aggregation sites such as HemOnc.org could not exist without primary sources. We access primary sources through a variety of means, including subscription to eTOCs, conference proceedings, and customized e-mail alerts through PubMed and other sources. This is a list of the sources that we use most frequently; decisions on whether to include treatment regimens are informed by our eligibility criteria.

"Top-tier" general medical journals

"Top-tier" hematology/oncology journals

Other hematology/oncology journals

Conference proceedings

E-mail Alerts